Molecular Insight Pharmaceuticals realigns to cut costs

01/7/2010 | MarketWire

Molecular Insight Pharmaceuticals, a developer of targeted drugs and imaging radiopharmaceuticals, has announced its plan to eliminate nine positions in order to cut costs and further support its oncology pipeline. The company expects to save about $1 million annually as a result of the move.

View Full Article in:

MarketWire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT